about
Antihypertensive drug therapy for mild to moderate hypertension during pregnancyAntihypertensive drug therapy for mild to moderate hypertension during pregnancyOral beta-blockers for mild to moderate hypertension during pregnancyUse of antihypertensive medications in pregnancy and the risk of adverse perinatal outcomes: McMaster Outcome Study of Hypertension In Pregnancy 2 (MOS HIP 2)Management of Type 1 Diabetes in PregnancyDrug treatment of hypertension in pregnancyA Comprehensive Review of Hypertension in PregnancyAn open trial comparing isradipine with hydralazine and methyl dopa in the treatment of patients with severe pre-eclampsiaPharmacodynamics of clonidine therapy in pregnancy: a heterogeneous maternal response impacts fetal growthFortnightly review: management of hypertension in pregnancy.Management of hypertension in pregnancy.Chronic hypertension in pregnancy.Fortnightly review: drug treatment during pregnancy.Impact of interventions to prevent and manage preeclampsia and eclampsia on stillbirths.Pregnancy in a patient with cancer and heart failure: challenges and complexities.Pre-eclampsia, eclampsia, and hypertensionReport of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy.How effective is antenatal care in preventing maternal mortality and serious morbidity? An overview of the evidence.Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.Pre-eclampsia, diagnosis and treatment.Pregnancy outcomes of anti-hypertensives for women with chronic hypertension: a population-based study.The effect of antihypertensive drugs on the fetus.Prescription drugs and pregnancy.The safety of antihypertensives for treatment of pregnancy hypertension.Randomised controlled trial of atenolol and pindolol in human pregnancy: effects on fetal haemodynamics.The management of pregnancy in hypertensive patientsPheochromocytoma after Cesarean Section.Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations.Pregnancy in women after coronary revascularizationHypertension in pregnancy: is it time for a new approach to treatment?The management of hypertension in pregnancy.Cardiac drug use in pregnancy: safety, effectiveness and obstetric implications.Short- and long-term strategies for the management of hypertensive disorders of pregnancy.Hypertensive disorders of pregnancy: preventative-, immediate- and long-term management.Nifedipine versus labetalol in the treatment of hypertensive disorders of pregnancy.Systematic review of phaeochromocytoma in pregnancy.Determinants of neonatal blood pressure.Use and impact of cardiac medication during pregnancy.Hypertension in pregnancy: natural history and treatment options.SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014.
P2860
Q24200520-FC74F475-0F96-40FC-B42D-D9A639E0D1C9Q24246376-6FE53BF0-6AEC-420D-BDF2-13707096A65CQ24248046-32E2AD7F-D30C-46B6-B5AF-7D14DAB99568Q24796129-FF54B42D-D4CD-45A6-BB98-F50DA4087AC7Q26747535-0DC1CCFF-B3C0-4442-BF65-F5FAED91D2ABQ27014718-5261BBB1-B9A2-4018-9E8E-17D7CBF0448EQ27495953-96C8AC43-E1AF-405E-89B5-557BE961CE65Q28290358-F1081FEE-4477-4E4C-AC16-84FC312AB4A7Q28743910-9726B6AB-A770-4057-A605-45EB96DB9B8CQ33633498-8DB04BDB-6C84-4153-816B-95C0DE8F96F1Q33697718-F22BAAA5-34A9-4CF7-A9B7-6A47FA8073A4Q33730179-DBA4C802-8417-42E2-9467-5353583BE5C8Q33792776-D040F50E-FEA0-41B1-B892-AAC750C4746DQ33875767-61E98996-C38A-4A07-B231-BF566DAD1FC0Q33885550-97517E07-19A3-4137-8D09-883B844957C5Q33947390-A136801F-9DE7-490F-8BE7-80EDD63D270FQ34026177-72C26951-D6A6-4C9C-B230-1E37D747C4AFQ34177612-A5D2FC51-1502-4B58-BE62-3F679235D0BEQ34299778-737E07B5-D237-4AD4-9488-06271F37857BQ34515491-8E24B18A-2A13-4C37-8F73-2367E2552A5DQ34583864-57A10A32-EF0A-45E1-B66D-755E459066D3Q34705302-A15B1108-A84B-42DB-8436-9BA35D2A0571Q35143961-67F89F84-41A0-4F3A-A4DA-B9F3F62AD868Q35609745-A0A1B4D2-102F-4B4B-83E0-8E4DA3A50DFCQ35822008-C75ED0D2-5849-4883-9813-F8DB78278D12Q36679357-43B4068D-9C55-4FF8-9A40-D9602474507FQ36732988-7B531A77-3B81-4D55-BF39-7257CA67F1C1Q37020820-6280DDF8-146A-41A4-A466-C077B735B687Q37070397-6EE2352A-BF4C-4E81-ACE1-581EA6931D4BQ37103553-9576FE2A-5035-44EA-BA19-975E06D6FAB3Q37586943-8882C825-69BB-4F18-BDFC-2A8ABE5E1550Q37642833-C73CF6D1-9D60-489D-9824-E332DA68DD74Q37642835-22BD1DA8-54EF-4A3A-AFE5-9B9FF976A46AQ37763163-35DB1B64-E16D-4B26-9583-7E63CA2325C8Q38009738-E9DAA54E-D31A-4F9D-90B0-370DF920C60FQ38062507-0F6FC886-CDDD-43C4-B794-52AB3E5FD24AQ38126802-3614CBF9-66FF-4B2C-A137-67F2F5D163AFQ38326668-0801235F-5E68-49DE-BD78-87C06C62320FQ38400715-E0FEFE5B-8A8F-4F51-BBAA-67739FC0EAC0Q38594110-A3A8B5EA-F7D6-429D-8A74-477EA243E38B
P2860
description
1990 nî lūn-bûn
@nan
1990 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Atenolol in essential hypertension during pregnancy
@ast
Atenolol in essential hypertension during pregnancy
@en
type
label
Atenolol in essential hypertension during pregnancy
@ast
Atenolol in essential hypertension during pregnancy
@en
prefLabel
Atenolol in essential hypertension during pregnancy
@ast
Atenolol in essential hypertension during pregnancy
@en
P2093
P2860
P356
P1433
P1476
Atenolol in essential hypertension during pregnancy
@en
P2093
P2860
P304
P356
10.1136/BMJ.301.6752.587
P407
P577
1990-09-01T00:00:00Z